All Publications

Export 170 results:
Author Title Type [ Year(Asc)]
2014
Laboratory adverse events and discontinuation of therapy according to CD4(+) cell count at the start of antiretroviral therapy. Jose S, Quinn K, Hill T, Leen C, Walsh J, Hay P, Fisher M, Post F, Nelson M, Gompels M et al. AIDS, 2014 Jun 01, Volume 28, Issue 9, p.1333-9, (2014)
Long-term mortality in HIV-positive individuals virally suppressed for >3 years with incomplete CD4 recovery. Engsig F, Zangerle R, Katsarou O, Dabis F, Reiss P, Gill J, Porter K, Sabin C, Riordan A, Fätkenheuer G et al. Clin Infect Dis, 2014 May, Volume 58, Issue 9, p.1312-21, (2014)
Predicted savings to the UK National Health Service from switching to generic antiretrovirals, 2014-2018 Hill A, Hill T, Jose S and Pozniak A. International Congress of Drug Therapy in HIV Infection, 2014, Volume J Int AIDS Soc 2014, 17(Suppl 3):19497, (2014)
Rate of viral load failure over time in people on ART in the UK Collaborative HIV Cohort (CHIC) study O'Connor J, Smith C, Lampe F, Johnson M, Sabin C and Phillips A. International Congress of Drug Therapy in HIV Infection, 2014, Volume J Int AIDS Soc 2014, 17(Suppl 3):19527, (2014)
Response to antiretroviral therapy (ART): comparing women with previous use of zidovudine monotherapy (ZDVm) in pregnancy with ART naïve women. Huntington S, Thorne C, Anderson J, Newell M, Taylor G, Pillay D, Hill T, Tookey P and Sabin C. BMC Infect Dis, 2014 Mar 04, Volume 14, p.127, (2014)
Spectrum of HIV-associated kidney disease in the era of combination antiretroviral therapy. Booth J, Hamzah L, Jose S, McAdoo S, Kumar E, Horsfield C, O'Donnell P, Jones R, Sabin C and Post F. Conference on retroviruses and opportunistic infections (CROI) 2014, Volume Top Antivir Med 2014;22(e-1):410, p.Abstract 793 Poster, (2014)
Treatment switches following periods of low-level viraemia Jose S, Smit E, Martin F, Dunn D, Mackie N, Churchill D and Sabin C. Third Joint Conference of the British HIV Association (BHIVA) with the British Association for Sexual Health and HIV (BASHH), 2014, Volume HIV Medicine 2014; 15 (Suppl. 3), 17-159, p.Poster 156, (2014)
Viral hepatitis testing patterns among HIV-positive individuals in the UK Collaborative HIV Cohort (UK CHIC) study Thornton A, Bhagani S, Burroughs A, Chadwick D, Dunn D, Fisher M, Gilson R, Jose S, Main J, Nelson M et al. Third Joint Conference of the British HIV Association (BHIVA) with the British Association for Sexual Health and HIV (BASHH), 2014, Volume HIV Medicine 2014; 15 (Suppl. 3), 17-159, p.Poster 236, (2014)
2013
Declining prevalence of HIV-1 drug resistance in antiretroviral treatment-exposed individuals in Western Europe. De Luca A, Dunn D, Zazzi M, Camacho R, Torti C, Fanti I, Kaiser R, Sönnerborg A, Codoñer F, Van Laethem K et al. J Infect Dis, 2013 Apr 15, Volume 207, Issue 8, p.1216-20, (2013)
Drug-resistance development differs between HIV-1-infected patients failing first-line antiretroviral therapy containing nonnucleoside reverse transcriptase inhibitors with and without thymidine analogues. Santoro M, Sabin C, Forbici F, Bansi L, Dunn D, Fearnhill E, Boumis E, Nicastri E, Antinori A, Palamara G et al. HIV Med, 2013 Oct, Volume 14, Issue 9, p.571-7, (2013)
Effects of age on antiretroviral plasma drug concentration in HIV-infected subjects undergoing routine therapeutic drug monitoring. Winston A, Jose S, Gibbons S, Back D, Stöhr W, Post F, Fisher M, Gazzard B, Nelson M, Gilson R et al. J Antimicrob Chemother, 2013 Jun, Volume 68, Issue 6, p.1354-9, (2013)
Failure to achieve an adequate CD4 count response despite regular engagement in HIV care and consistent viral suppression O'Connor J, Smith C, Lampe F, Johnson M, Sabin C and Phillips A. 19th Annual Conference of the British HIV Association (BHIVA), 2013. Poster 46, Volume HIV Medicine 2013; 14 (Suppl. 2), 12-77, p.Poster 46, (2013)
HIV-1 subtype and virological response to antiretroviral therapy: a confirmatory analysis. Dolling D, Dunn D, Geretti A and Sabin C. Clin Infect Dis, 2013 Jan, Volume 56, Issue 1, p.162-3, (2013)
HLA B*5701 positivity, disease status and response to combination antiretroviral therapy (cART) in the UK Collaborative HIV Cohort (CHIC) study Jose S, Sabin C, Leen C, Chadwick D and for the UK CHIC Study. 19th Annual Conference of the British HIV Association (BHIVA), 2013, Volume HIV Medicine 2013; 14 (Suppl. 2), 12-77, p.Poster 144, (2013)
HLA B*5701 status, disease progression, and response to antiretroviral therapy. . AIDS, 2013 Oct 23, Volume 27, Issue 16, p.2587-92, (2013)
The impact of age on associations between HIV-disease markers (immunological and virological) and systemic markers of metabolic function in therapy-naïve HIV-infected subjects in the UK Collaborative HIV Cohort (CHIC) Samuel M, Jose S, Winston A and Sabin C. 19th Annual Conference of the British HIV Association (BHIVA), 2013, Volume HIV Medicine 2013; 14 (Suppl. 2), 12-77, p.Poster 82, (2013)
The impact of HIV-1 reverse transcriptase polymorphisms on responses to first-line nonnucleoside reverse transcriptase inhibitor-based therapy in HIV-1-infected adults. Mackie N, Dunn D, Dolling D, Garvey L, Harrison L, Fearnhill E, Tilston P, Sabin C and Geretti A. AIDS, 2013 Sep 10, Volume 27, Issue 14, p.2245-53, (2013)
The incidence of AIDS-defining illnesses at a current CD4 count ≥ 200 cells/μL in the post-combination antiretroviral therapy era. Mocroft A, Furrer H, Miro J, Reiss P, Mussini C, Kirk O, Abgrall S, Ayayi S, Bartmeyer B, Braun D et al. Clin Infect Dis, 2013 Oct, Volume 57, Issue 7, p.1038-47, (2013)
Low frequency of genotypic resistance in HIV-1-infected patients failing an atazanavir-containing regimen: a clinical cohort study. Dolling D, Dunn D, Sutherland K, Pillay D, Mbisa J, Parry C, Post F, Sabin C and Cane P. J Antimicrob Chemother, 2013 Oct, Volume 68, Issue 10, p.2339-43, (2013)
Predictors of CD4(+) T-cell counts of HIV type 1-infected persons after virologic failure of all 3 original antiretroviral drug classes. Costagliola D, Ledergerber B, Torti C, van Sighem A, Podzamczer D, Mocroft A, Dorrucci M, Masquelier B, De Luca A, Jansen K et al. J Infect Dis, 2013 Mar 01, Volume 207, Issue 5, p.759-67, (2013)
Predictors of pregnancy and changes in pregnancy incidence among HIV-positive women accessing HIV clinical care. Huntington S, Thorne C, Bansi L, Anderson J, Newell M, Taylor G, Pillay D, Hill T, Tookey P and Sabin C. AIDS, 2013 Jan 02, Volume 27, Issue 1, p.95-103, (2013)
Rapid Increase in the Frequency of Wild Type HIV-1 Drug Resistance Reports among ART-experienced Patients: UK Dolling D, Nelson M, Schwenk A, Churchill D, Pillay D, Dunn D and UK HIV Drug Resistance Database and UK Collaborative HIV Cohort Study. 20th Conference on Retroviruses and Opportunistic Infections, 2013, (2013)
Risk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE). Mocroft A, Lundgren J, Sabin M, Monforte A, Brockmeyer N, Casabona J, Castagna A, Costagliola D, Dabis F, De Wit S et al. PLoS Med, 2013, Volume 10, Issue 9, p.e1001510, (2013)
Second-line protease inhibitor-based antiretroviral therapy after non-nucleoside reverse transcriptase inhibitor failure: the effect of a nucleoside backbone. Waters L, Bansi L, Asboe D, Pozniak A, Smit E, Orkin C, Fearnhill E, Dunn D and Phillips A. Antivir Ther, 2013, Volume 18, Issue 2, p.213-9, (2013)
2012
All-cause mortality in treated HIV-infected adults with CD4 ≥500/mm3 compared with the general population: evidence from a large European observational cohort collaboration. Lewden C, Bouteloup V, De Wit S, Sabin C, Mocroft A, Wasmuth J, van Sighem A, Kirk O, Obel N, Panos G et al. Int J Epidemiol, 2012 Apr, Volume 41, Issue 2, p.433-45, (2012)